Paycor HCM (NASDAQ:PYCR) Price Target Raised to $22.50

Paycor HCM (NASDAQ:PYCRFree Report) had its target price boosted by Mizuho from $20.00 to $22.50 in a report issued on Wednesday,Benzinga reports. They currently have a neutral rating on the stock.

PYCR has been the subject of a number of other reports. The Goldman Sachs Group boosted their price objective on shares of Paycor HCM from $19.00 to $21.00 and gave the stock a “neutral” rating in a report on Tuesday, November 26th. BMO Capital Markets restated a “market perform” rating and issued a $22.50 price target (down previously from $24.00) on shares of Paycor HCM in a research note on Wednesday. Citigroup increased their price objective on Paycor HCM from $15.00 to $16.00 and gave the company a “neutral” rating in a research report on Wednesday, September 25th. JMP Securities reissued a “market outperform” rating and issued a $30.00 target price on shares of Paycor HCM in a research report on Monday, January 6th. Finally, Jefferies Financial Group raised their price target on shares of Paycor HCM from $13.00 to $15.00 and gave the company a “hold” rating in a report on Tuesday, October 22nd. Nine investment analysts have rated the stock with a hold rating and seven have given a buy rating to the company. According to data from MarketBeat, the stock presently has an average rating of “Hold” and a consensus target price of $20.91.

View Our Latest Research Report on PYCR

Paycor HCM Stock Performance

NASDAQ:PYCR opened at $22.15 on Wednesday. The firm has a market cap of $3.98 billion, a P/E ratio of -85.19, a P/E/G ratio of 4.79 and a beta of 0.50. Paycor HCM has a fifty-two week low of $10.92 and a fifty-two week high of $23.49. The firm has a 50-day simple moving average of $18.68 and a two-hundred day simple moving average of $15.28.

Insider Buying and Selling

In other Paycor HCM news, Director Jeremy Rishel sold 3,723 shares of the company’s stock in a transaction that occurred on Wednesday, October 16th. The shares were sold at an average price of $14.02, for a total value of $52,196.46. Following the completion of the transaction, the director now directly owns 21,218 shares in the company, valued at $297,476.36. This represents a 14.93 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. 1.39% of the stock is owned by insiders.

Institutional Trading of Paycor HCM

Several institutional investors and hedge funds have recently added to or reduced their stakes in PYCR. Diversified Trust Co purchased a new position in Paycor HCM during the fourth quarter valued at $273,000. Principal Financial Group Inc. purchased a new position in shares of Paycor HCM during the third quarter valued at about $962,000. Franklin Resources Inc. increased its holdings in shares of Paycor HCM by 2.7% in the third quarter. Franklin Resources Inc. now owns 1,734,109 shares of the company’s stock worth $23,220,000 after purchasing an additional 46,127 shares during the last quarter. Barclays PLC lifted its position in shares of Paycor HCM by 50.8% in the third quarter. Barclays PLC now owns 23,991 shares of the company’s stock worth $340,000 after buying an additional 8,079 shares in the last quarter. Finally, Neo Ivy Capital Management bought a new position in Paycor HCM during the third quarter valued at approximately $912,000. Institutional investors own 36.76% of the company’s stock.

About Paycor HCM

(Get Free Report)

Paycor HCM, Inc, together with its subsidiaries, provides software-as-a-service (SaaS) human capital management (HCM) solutions for small and medium-sized businesses (SMBs) primarily in the United States. It offers cloud-native platform to address the comprehensive people management needs of SMB leaders.

Featured Articles

Analyst Recommendations for Paycor HCM (NASDAQ:PYCR)

Receive News & Ratings for Paycor HCM Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Paycor HCM and related companies with MarketBeat.com's FREE daily email newsletter.